q.beyond AG (0CHZ)
London Stock Exchange · UK · prices in EUR · close of 26 Oct 2026
Key indicators
| Last close | EUR 2.840 |
|---|---|
| 52-week range | 2.800 – 4.460 |
| Return, 1 month / 3 months | −17.0% / −17.4% |
| Return, 1 year / 3 years | −34.9% / −6.3% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 42.6% |
| Worst drawdown (1 year) | -37.6% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
q.beyond AG is a German information technology services company based in Cologne. It helps business customers with cloud services, SAP consulting and managed information technology, and it also operates network and data centre infrastructure. Its clients are mainly small and medium-sized enterprises and public-sector organisations that rely on the company to run and modernise their systems. The firm advises on digital projects and provides ongoing support for networks, applications and workplace technology.
q.beyond AG trades under the code 0CHZ on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
q.beyond AG (0CHZ) trades on the London Stock Exchange in UK. It last closed at EUR 2.840 on 26 October 2026.
Its price-based Market X-Ray is 22 out of 100 (a weak price profile), ranking 3,361 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 34.9% and over the last three months it fell 17.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 22 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.2% | ||
| From 52-week high | -34.4% | ||
| Momentum | 17 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.4% | ||
| 6-month return | -22.8% | ||
| 12-month return, skipping the last month | -21.6% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.6% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −15.0% |
|---|---|
| 1 month | −17.0% |
| 3 months | −17.4% |
| 6 months | −22.8% |
| 1 year | −34.9% |
| 3 years | −6.3% |
| 5 years | −71.5% |
Signals
| 50-day / 200-day average | 3.391 / 3.606 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.098 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 May 2020 | EUR 0.0300 |
| 30 May 2019 | EUR 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.